Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance

Acta Diabetologica

Volumn 40, Issue 4, 2003, Pages 181-186

  Mannucci, E ^a,b   Ognibene, A ^c   Sposato, I ^a,c   Brogi, M ^c   Gallori, G ^c   Bardini, G ^a   Cremasco, F ^a   Messeri, G ^c   Rotella, C M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Diabetes; Glycated haemoglobin; Impaired glucose tolerance; Oral glucose tolerance test; Screening

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; CASE FINDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC OBESITY; DIAGNOSTIC TEST; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RISK; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS; FASTING; FEMALE; FRANCE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; REPRODUCIBILITY OF RESULTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS;

EID: 0346734378     PISSN: 09405429     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00592-003-0109-8     Document Type: Article

References (24)

1. - (1997) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
2. Mannucci E, Bardini G, Ognibene A, Rotella CM (1998) Screening for diabetes in obese patients using the new diagnostic criteria. Diabetes Care 21:468 (letter)
3. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group (1999) Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. Diabetologia 42:647-654
4. Alberti KGMM, Zimmet PZ, for the WHO Consultation (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabet Med 15:539-553
5. Peters AL, Davidson MB, Schriger DL, Hasselblad V (1996) A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Metaanalysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. JAMA 276:1246-1252
6. Tanaka Y, Atsumi Y, Matsukoa K, Mokubo A, Asahina T, Hosokawa K, Shimada R, Matsunaga H, Takagi M, Ogawa O, Onuma T, Kawamori R (2001) Usefulness of stable HbA1C for supportive marker to diagnose diabetes mellitus in Japanese subjects. Diabetes Res Clin Pract 53:41-45
7. Tsuji I, Nakamoto K, Hasegawa T, Hisashige A, Iwanashiro H, Fukao A, Hisamic S (1991) Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening. Diabetes Care 14:1075-1077
8. Narayan KM, Hanson RL, Pettitt DJ, Bennett PH, Knowler WC (1996) A two-step strategy for identification of high-risk subjects for a clinical trial of prevention of NIDDM. Diabetes Care 19:972-978
9. 1C measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care 24:465-471
10. 1C measurements do not improve the detection of type 2 diabetes in a randomly selected population. Diabetes Care 24:2017-1018 (letter)
11. Uusitupa M, Louheranta A, Lindstrom J, Valle T, Sundvall J, Eriksson J, Tuomilheto J (2000) The Finnish Diabetes Prevention Study. Br J Nutr 83[Suppl]:S137-S142
12. Haffner SM (2002) Can reducing peaks prevent type 2 diabetes: implication from recent diabetes prevention trials. Int J Clin Pract Suppl 129:33-39
13. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Hasaki KA, Laakso M (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072-2077
14. Mannucci E, Bardini G, Ognibene A, Rotella CM (1999) Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients. Diabet Med 16:579-585
15. De Vegt F, Dekker JM, Jager A, Heinkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 285:2109-2113
16. Alberti KGMM (1996) The clinical implications of impaired glucose tolerance. Diabet Med 13:927-937
17. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary heart disease risk and impaired glucose tolerance: the Whitehall Study. Lancet i:1373-1376
18. Haffner SM (1998) The importance of hyperglycemia in non-fasting state to the development of cardiovascular disease. Endocr Rev 19:583-592
19. Tominaga M, Eguchi H, Manaka H, Igarashi K, Kato T, Sekikawa A (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study. Diabetes Care 22:920-924
20. Motala AA, Omar MA (1992) The value of glycated haemoglobin as a substitute for the oral glucose tolerance test in the detection of impaired glucose tolerance (IGT). Diabetes Res Clin Pract 17:199-207
21. 1C measurement for diabetes among subjects with a previous history of impaired glucose tolerance. Diabetes Res Clin Pract 30:189-194
22. - (1997) Preventing and managing the global epidemic of obesity: report of the World Health Organization Consultation of Obesity. WHO, Geneva
23. McCance DR, Hanson RL, Charles MA, Jacobson LTH, Pettitt DJ, Bennett PH, Knowler WC (1994) Comparison of tests for glycated haemoglobin and fasting and two-hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308:1323-1328
24. Finch CF, Zimmet PA, Alberti KGMM (1990) Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentrations? Diabet Med 7:603-610